**Core Concept**
Perampanel is a medication used in the management of epilepsy, specifically for the treatment of focal seizures and generalized tonic-clonic seizures. It acts by inhibiting a specific subtype of glutamate receptors, which play a crucial role in the excitatory neurotransmission and seizure generation.

**Why the Correct Answer is Right**
Perampanel is a selective, non-competitive antagonist of the AMPA (α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor subtype of glutamate receptors. By blocking the AMPA receptors, perampanel reduces the excitatory neurotransmission and subsequently decreases the frequency and severity of seizures. This mechanism of action makes perampanel an effective adjunctive therapy for patients with epilepsy who are not adequately controlled with other antiepileptic medications.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because perampanel is not a benzodiazepine. While benzodiazepines can be used as adjunctive therapy for epilepsy, perampanel's mechanism of action is distinct from that of benzodiazepines.

**Option B:** This option is incorrect because perampanel is not a GABA (gamma-aminobutyric acid) receptor agonist. GABA receptor agonists, such as benzodiazepines and barbiturates, increase the inhibitory neurotransmission, whereas perampanel decreases the excitatory neurotransmission.

**Option C:** This option is incorrect because perampanel is not a sodium channel blocker. Sodium channel blockers, such as carbamazepine and phenytoin, reduce the frequency and severity of seizures by blocking the sodium channels in the neuronal membranes.

**Clinical Pearl / High-Yield Fact**
One key aspect of perampanel's mechanism of action is its selectivity for the AMPA receptor subtype, which makes it an effective treatment for epilepsy without significant side effects associated with non-selective glutamate receptor antagonists.

**Correct Answer:** C.